AXSM - Axsome Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5855.65M
Enterprise Value 3813.56M
Trailing P/E N/A
Forward P/E 1-19.57
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)35.16
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-19.70

Trading Information

Stock Price History

Beta (3Y Monthly) 2.85
52-Week Change 3970.87%
S&P500 52-Week Change 30.90%
52 Week High 328.70
52 Week Low 31.94
50-Day Moving Average 325.91
200-Day Moving Average 318.59

Share Statistics

Avg Vol (3 month) 31.07M
Avg Vol (10 day) 3872k
Shares Outstanding 525.55M
Float 22.76M
% Held by Insiders 127.32%
% Held by Institutions 117.42%
Shares Short (Jul 31, 2019) 45.91M
Short Ratio (Jul 31, 2019) 46.81
Short % of Float (Jul 31, 2019) 423.46%
Short % of Shares Outstanding (Jul 31, 2019) 417.23%
Shares Short (prior month Jun 28, 2019) 45.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-67.56%
Return on Equity (ttm)-270.24%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -41.3M
Net Income Avi to Common (ttm)-42.28M
Diluted EPS (ttm)-1.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)53.75M
Total Cash Per Share (mrq)1.56
Total Debt (mrq)19.58M
Total Debt/Equity (mrq)80.63
Current Ratio (mrq)4.18
Book Value Per Share (mrq)0.71

Cash Flow Statement

Operating Cash Flow (ttm)-33.89M
Levered Free Cash Flow (ttm)-18.07M